Conference Title
Location
Day Month Year
Conference Supporting Journal
The 6th Vaccine Congress is sponsored and hosted by Vaccine in collaboration with the International Society for Vaccines. Vaccine, an Elsevier publication now in its 30th year, is the pre-eminent journal for those interested in vaccines and vaccination. It serves as an interface between academics, those in research and development, and workers in the field. Relevant topics range from basic vaccine research through to vaccine applications, safety and legislation.
For further information please visit: http://www.elsevier.com/locate/vaccine
Most cited articles from 2010
Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial.
Roman, F., Vaman, T., Gerlach, B., Markendorf, A., Gillard, P., & Devaster, J. -. (2010).
Vaccine, 28(7), 1740-1745.
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, west nile and japanese encephalitis viruses.
Guy, B., Guirakhoo, F., Barban, V., Higgs, S., Monath, T. P., & Lang, J. (2010).
Vaccine, 28(3), 632-649.
The 2009 A (H1N1) influenza virus pandemic: A review.
Girard, M. P., Tam, J. S., Assossou, O. M., & Kieny, M. P. (2010).
Vaccine, 28(31), 4895-4902.
Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study.
Leroux-Roels, I., Roman, F., Forgus, S., Maes, C., De Boever, F., Dramé, M., et al. (2010).
Vaccine, 28(3), 849-857.
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived mycobacterium tuberculosis specific T cell responses in naïve human volunteers.
van Dissel, J. T., Arend, S. M., Prins, C., Bang, P., Tingskov, P. N., Lingnau, K., et al. (2010).
Vaccine, 28(20), 3571-3581.
